S-17828

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameS-17828
Drug Alias NameS-17828
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors alpha-2 antagonistsSerotonin 2a (5-HT2a) receptor antagonistsDopamine D3 receptor antagonists +[4] 
TargetsSerotonin 2a (5-HT2a) receptorAdrenergic receptors alpha-2Dopamine D3 receptor +[4] 
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLaboratoires Servier
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLaboratoires Servier
Active IndicationsN/A
Inactive IndicationsSchizophrenia

Other Information

ATC CodeN/A
Related LinksN/A